These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 9463487)
21. Real-time tilting and twisting motions of ligand-bound states of α7 nicotinic acetylcholine receptor. Yang Y; Arai T; Sasaki D; Kuramochi M; Inagaki H; Ohashi S; Sekiguchi H; Mio K; Kubo T; Sasaki YC Eur Biophys J; 2024 Feb; 53(1-2):15-25. PubMed ID: 38233601 [TBL] [Abstract][Full Text] [Related]
22. Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator. Collins T; Millar NS Mol Pharmacol; 2010 Aug; 78(2):198-204. PubMed ID: 20463059 [TBL] [Abstract][Full Text] [Related]
23. Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Toulmé E; Soto F; Garret M; Boué-Grabot E Mol Pharmacol; 2006 Feb; 69(2):576-87. PubMed ID: 16282518 [TBL] [Abstract][Full Text] [Related]
24. Differential Activation and Desensitization States Promoted by Noncanonical Stokes C; Camacho-Hernandez GA; Thakur GA; Wu X; Taylor P; Papke RL J Pharmacol Exp Ther; 2022 Nov; 383(2):157-171. PubMed ID: 36279397 [TBL] [Abstract][Full Text] [Related]
25. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Zwart R; Vijverberg HP Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980 [TBL] [Abstract][Full Text] [Related]
26. Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes. Zwart R; Strotton M; Ching J; Astles PC; Sher E Eur J Pharmacol; 2014 Mar; 726():77-86. PubMed ID: 24485886 [TBL] [Abstract][Full Text] [Related]
27. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators. Broad LM; Zwart R; Pearson KH; Lee M; Wallace L; McPhie GI; Emkey R; Hollinshead SP; Dell CP; Baker SR; Sher E J Pharmacol Exp Ther; 2006 Sep; 318(3):1108-17. PubMed ID: 16738207 [TBL] [Abstract][Full Text] [Related]
28. The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist. Macor JE; Gurley D; Lanthorn T; Loch J; Mack RA; Mullen G; Tran O; Wright N; Gordon JC Bioorg Med Chem Lett; 2001 Feb; 11(3):319-21. PubMed ID: 11212100 [TBL] [Abstract][Full Text] [Related]
29. Rhesus monkey alpha7 nicotinic acetylcholine receptors: comparisons to human alpha7 receptors expressed in Xenopus oocytes. Papke RL; McCormack TJ; Jack BA; Wang D; Bugaj-Gaweda B; Schiff HC; Buhr JD; Waber AJ; Stokes C Eur J Pharmacol; 2005 Nov; 524(1-3):11-8. PubMed ID: 16266703 [TBL] [Abstract][Full Text] [Related]
30. A series of α7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties. Gill JK; Dhankher P; Sheppard TD; Sher E; Millar NS Mol Pharmacol; 2012 May; 81(5):710-8. PubMed ID: 22328718 [TBL] [Abstract][Full Text] [Related]
31. Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. Palma E; Mileo AM; Eusebi F; Miledi R Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11231-5. PubMed ID: 8855338 [TBL] [Abstract][Full Text] [Related]
32. Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line. Roncarati R; Seredenina T; Jow B; Jow F; Papini S; Kramer A; Bothmann H; Dunlop J; Terstappen GC Assay Drug Dev Technol; 2008 Apr; 6(2):181-93. PubMed ID: 18471073 [TBL] [Abstract][Full Text] [Related]
33. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107. Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915 [TBL] [Abstract][Full Text] [Related]
34. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004 [TBL] [Abstract][Full Text] [Related]
35. Macroscopic and Microscopic Activation of Quadri M; Garai S; Thakur GA; Stokes C; Gulsevin A; Horenstein NA; Papke RL Mol Pharmacol; 2019 Jan; 95(1):43-61. PubMed ID: 30348894 [TBL] [Abstract][Full Text] [Related]
36. Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity. Texidó L; Ros E; Martín-Satué M; López S; Aleu J; Marsal J; Solsona C Br J Pharmacol; 2005 Jul; 145(5):672-8. PubMed ID: 15834443 [TBL] [Abstract][Full Text] [Related]
37. Neuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine. Palma E; Maggi L; Eusebi F; Miledi R Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9915-9. PubMed ID: 9275226 [TBL] [Abstract][Full Text] [Related]